# Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT)

> **NCT07369232** · NA · RECRUITING · sponsor: **Erasme University Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Oxygen
- Hyperoxemia
- Antioxidant
- Cerebral Autoregulation
- Oxidative Stress

## Interventions

- **OTHER:** Oxygen
- **DRUG:** Vitamin C (Ascorbic Acid)

## Key facts

- **NCT ID:** NCT07369232
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-02-28
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-01-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07369232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07369232, "Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07369232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*